Phase III trial
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Phase III trial
Sep 14, 2024, 12:01 |
Blog
Zhen Su: Phase III NSCLC results are out – Ivonescimab vs. Pembrolizumab!
Zhen Su, CEO at Marengo Therapeutics, posted the following on LinkedIn: “Phase III NSCLC Ivonescimab (Anti-VEGF/PD-1…
Aug 26, 2024, 21:24 |
Blog
Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC
Tanja Obradovic posted on LinkedIn: “Can we expect new EGFR TKI that can significantly surpass…
Aug 2, 2024, 14:00 |
Insight
Alessandro Santin: This is a major 'bench-to-bedside' accomplishment for uterine cancer patients
Yale Cancer Center made the following post on X: "Led by Dr. Alessandro Santin and researchers…
Jun 18, 2024, 03:30 |
Blog
Ruben Mesa: Most active combination for MF to date
Ruben Mesa shared on LinkedIn: "Honored to be a Co-Investigator of important Pelabresib plus RUX 1L…
May 21, 2024, 12:01 |
Blog
Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors
Jarushka Naidoo shared on X/Twitter: "Phase III trial methylphenidate versus placebo for cancer fatigue in advanced…
Apr 29, 2024, 15:54 |
Insight
Toni Choueiri: Big news to start the day: DESTINY-Breast06 Phase III trial
Toni Choueiri shared on X: "Big news to start the day: DESTINY-Breast06 Phase III trial…
All:
6
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube